anti-VEGF-B antibody (Karolinska Institutet)

N/A

Report date: 2025/03/14 16:42:19

Base Information

Drug Nameanti-VEGF-B antibody (Karolinska Institutet)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionVascular endothelial growth factor B inhibitors
TargetsVascular endothelial growth factor B
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKarolinska Institutet
China Registration ClassN/A

Develop Information

Active CompaniesKarolinska Institutet
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A